Impact of skeletal muscle index (SMI) loss during palliative systemic treatment (Tx) on time to progression and overall survival (OS) in metastatic colorectal cancer (mCRC) patients.Sophie A. Kurk, Anne M. May, Marion Jourdan et al.|Journal of Clinical Oncology|2017Cited by 6
Impact of sarcopenia on dose limiting toxicities in metastatic colorectal cancer patients (mCRC pts) receiving palliative systemic treatmentSophie A. Kurk, Anne M. May, Petra H.M. Peeters et al.|Annals of Oncology|2017Cited by 4